What drug class is bivalirudin?
Angiomax is a prescription medicine used to treat the symptoms of blood clots (Percutaneous Coronary Intervention). Angiomax may be used alone or with other medications. Angiomax belongs to a class of drugs called Anticoagulants, Cardiovascular; Anticoagulants, Hematologic.
Is bivalirudin a direct thrombin inhibitor?
Hirudin, bivalirudin, and argatroban are the 3 parenteral direct thrombin inhibitors currently approved by the US Food and Drug Administration.
Is bivalirudin an antiplatelet?
We tested the hypothesis that bivalirudin acts as an antiplatelet agent in PCI patients by preventing activation of PARs on the platelet surface. Methods and Results—The effect of bivalirudin on platelet function and systemic thrombin levels was assessed in patients undergoing elective PCI.
Where is bivalirudin metabolized?
Bivalirudin
| Clinical data | |
|---|---|
| Bioavailability | N/A (IV application only) |
| Metabolism | Angiomax is cleared from plasma by a combination of renal mechanisms and proteolytic cleavage |
| Elimination half-life | ~25 minutes in patients with normal renal function |
| Identifiers |
Does bivalirudin affect INR?
Bivalirudin’s effects on elevating the INR range from 0.37 to 0.55 over the course of therapy initiation and decreased the INR by 0.48 on bivalirudin discontinuation. It is reasonable to target a higher INR goal (INR > 2.5 for INR goal 2.0-3.0 or INR > 3.0 for INR goal 2.5-3.5) when bridging to warfarin.
Is bivalirudin a blood thinner?
Bivalirudin is an anticoagulant (thrombin inhibitor) that helps prevent the formation of blood clots. Bivalirudin is used to prevent blood clots in people with severe chest pain or other conditions who are undergoing a procedure called angioplasty (to open blocked arteries).
Does bivalirudin affect aPTT?
According to our institutional guideline, bivalirudin is therapeutic at an aPTT between 60 and 80 seconds.
Does bivalirudin increase INR?
Does angiomax effect act?
The approved product labeling for Angiomax states that, in adults, IV bivalirudin produces dose- dependent prolongation of anticoagulant activity as measured by activated partial thromboplastin time (aPTT), thrombin time (TT), prothrombin time (PT), and activated clotting time (ACT).
How is bivalirudin given?
Bivalirudin is given as an infusion into a vein. A healthcare provider will give you this injection during your angioplasty procedure. Your doctor may want you to continue receiving bivalirudin for a few hours after your angioplasty procedure. Bivalirudin can make it easier for you to bleed, even from a minor injury.
Does bivalirudin increase PTT?
PTT (s): last measured PTT value. INR (unit-less): the last measured INR value – a coagulation time that is distinct, but associated with the PTT. It increases as the serum level of bivalirudin increases.
Is bivalirudin approved for HIT?
Bivalirudin is the most recent direct thrombin inhibitor to be introduced to the market, but it is not currently FDA approved for HIT.
Does bivalirudin affect PTT?
What is bivalirudin used for?
Bivalirudin is a medication used to manage and treat patients undergoing percutaneous coronary intervention for acute myocardial infarction. It is in the direct thrombin inhibitor class of drugs.
How does bivalirudin affect PTT?
Decreased GFR would increase the serum level of bivalirudin and the PTT in an approximately linear fashion [12]. PTT (s): last measured PTT value. INR (unit-less): the last measured INR value – a coagulation time that is distinct, but associated with the PTT. It increases as the serum level of bivalirudin increases.
When do you use argatroban vs bivalirudin?
Average time to initial therapeutic anticoagulation was 4.71 hours and 9.8 hours for the argatroban and bivalirudin groups, respectively (P < . 01). Conclusions: Argatroban may be advantageous compared to bivalirudin in achieving initial therapeutic anticoagulation goals among patients with suspected or confirmed HIT.
What is the indication for bivalirudin?
Bivalirudin is indicated for use in patients undergoing percutaneous coronary intervention (PCI), in patients at moderate to high risk acute coronary syndromes due to unstable angina or non-ST segment elevation in whom a PCI is planned.
How do you monitor bivalirudin?
At UWMC, bivalirudin is monitored using the Direct Thrombin Inhibitor (DTI) assay (Plasma-Diluted Thrombin Time). Used instead of aPTT to monitor injectable DTI therapy. Preferred over aPTT due to better sensitivity, and is not affected by antiphospholipid antibodies.
How do you administer bivalirudin?
The recommended dose of bivalirudin for patients undergoing PCI is an intravenous bolus of 0.75 mg/kg body weight followed immediately by an intravenous infusion at a rate of 1.75 mg/kg body weight/hour for at least the duration of the procedure.